Navigation Links
URMC, FDA to collaborate on national data repository for heart research
Date:7/9/2008

The University of Rochester Medical Center (URMC) will collaborate with the U.S. Food and Drug Administration (FDA) to develop a national repository of data that will aid academic and industry researchers studying the electrical activity of the heart. In addition to helping researchers understand many cardiac problems, the data may aid the development of new tools to detect drugs that can have dangerous effects on the heart.

The repository will include thousands of electrocardiogram (ECG) recordings from cardiac patients and healthy volunteers who have worn small devices to monitor their heart activity, usually for hours or days at a time. It includes ECG recordings of rare events, including dangerous heart-rhythm problems that were triggered by certain drugs.

Researchers at URMC have been collecting and studying the ECG data for decades through the university's Heart Research Follow-Up Program. The data repository, which will be owned and maintained by URMC, will be called the Telemetric and Holter Electrocardiogram Warehouse, or THEW. An agreement signed by URMC and FDA establishes both parties' intent to work together, under the auspices of a public-private partnership, to use the THEW data to address public health needs in the area of cardiac safety.

Access to the THEW data by outside researchers will be governed by an executive committee that includes representatives from URMC, FDA, industry, academia, and other stakeholders. Representatives from FDA will provide scientific input on research projects aimed at improving drug safety, such as identifying patterns in ECG data that reveal drug side effects, and the development of computer software that scan large amounts of ECG data to spot those patterns.

"The goal of this program is to give companies and not-for-profit organizations the ability to develop and validate new technologies and advance the field of quantitative electrocardiology," said URMC biomedical engi
'/>"/>

Contact: Karin Christensen
Karin_Christensen@urmc.rochester.edu
585-275-1311
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Associates of Cape Cod (ACC) and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform
2. Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
3. Mylan Inc., NATCO Pharma Ltd. To Collaborate on Worldwide Marketing and Distribution of Generic Copaxone(R)
4. MedTrust Online Collaborates With Oracle and Dell to Provide Oncologists With the Next Generation Tool for Personalized Care Delivery
5. Endovascular Forum and CiDA Collaborate to Launch a Collective Intelligence Instrument for Dialysis Access Physicians
6. Mount Tabor Collaborates with Google Health
7. HHS, Cleveland Clinic Collaborate to Advance Treatment for Neurological Disorders
8. Leading HIV researchers to collaborate on vaccine development
9. The Feinstein to collaborate with Swedens Karolinska Institute
10. The Wistar Institute collaborates with the Coriell Institute to distribute cell lines
11. INCF and Allen Institute for Brain Science collaborate on Brain Atlas service improvement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...eClaim Revenue Gateway Alleviates Insurance Claim ...roviders , , ATLANTA, Dec. 2 /PRNewswire-Fi...day announced a new healthcare receivables solutio...s well as hospitals. SunTrust eClaim Revenue Gatew...issions as well as payment collection and processi...
(Date:12/2/2008)...o., Dec. 2 MicroPhage, Inc., htt... M. Taussig, MD has joined,the company,s Board of...onal,Jewish Medical and Research Center in Denver...espiratory diseases, from 1993 to 2006. His medic...I have followed MicroPhage extensively and am impr...
(Date:12/2/2008)...s Missing Opportunities to Connect - , , - ...escription Drug Abuse Dangers - , , NEW YOR...Partnership for a Drug-Free America and MetLife Fo...ail or text messaging to communicate with their t...nect with their kids about drug and alcohol use. T...
(Date:12/2/2008)...OCKVILLE, Md., Dec. 2 F...iods and increased supervision of work hour limits...nment, according to a new Institute of Medicine re... and Quality. , , The report is the result...ewed the relationship between residents, work sche...
Breaking Medicine News(10 mins):Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 2Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 3Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 4Health News:MicroPhage Selects Lynn Taussig, MD for Board of Directors 2Health News:Bridging the Technology Gap: Study Confirms Teens Open to Discussing Drugs and Alcohol With Parents By Email, Cell Phones 2Health News:Bridging the Technology Gap: Study Confirms Teens Open to Discussing Drugs and Alcohol With Parents By Email, Cell Phones 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 2Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 4
...n with prostate cancer who receive a common medica...uce // the risk of recurrence after surgery may be...he research showed men treated with androgen depri...er run a higher risk of developing the bone-thinni...
... might benefit from the implantation of cardiac pa...t the conclusion // after studying 20 patients wit...currence of interrupted heart rhythm during seizur...ring seizures might be responsible for the higher ...
...e drug rolipram in mice shows promise for possible...say researchers according to a new study. Alzheime... the elderly with typical symptoms being memory lo... changes. The main factor in the cause of AD is th...
...vaginal birth after first delivering a child via c...r newborns at risk,// say researchers based on fin... anything will go wrong is extremely small, uterin...n due to lack of oxygen (hypoxic-ischemic encephal...
Other Medicine News:
(Date:12/1/2008)...e study shows the Prox1 gene is a two-way switch t...ells to be reprogrammed so that they lose their id...s , , MEMPHIS, Tenn., Dec. 1 /PRNewswire-US...search Hospital have discovered that a certain dif...entity that it requires the constant expression of...
(Date:12/1/2008)...STGARD, Denmark, December 1 /PRNewswire-FirstCall/...07 with the intent to procure an MVA-based,third...ernment Services,Canada, on behalf of the Canadia...ontract to Bavarian Nordic for the delivery of IMV... to use IMVAMUNE(R) as part of the,country,s bio-...
(Date:12/1/2008)...GO, Dec. 1 Vical Incorpo...t of a $1.0 million milestone payment from Merck &... of a Phase I clinical trial of an investigational...vaccine is based on Vical,s DNA gene delivery tech...riptase (hTERT). hTERT is the subject of separate ...
(Date:11/28/2008)...RLITZ, Germany, November 28 German...eadership in specialized HIV monitoring and,AIDS ...merging countries. In,the year 2008, 2.5 million ...le, robust and highly affordable "CyFlow" system, ...ing with HIV/AIDS. Due to introduction of the,Par...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Fantastic photographs of fluorescent fish 4890 1Old and new therapies combine to tackle atherosclerosis 7697 1Old and new therapies combine to tackle atherosclerosis 7697 2Old and new therapies combine to tackle atherosclerosis 7697 3Water purification down the nanotubes 7695 1Water purification down the nanotubes 7695 2Cadence Pharmaceuticals Updates Omigard 28TM 29 Clinical Timeline 3058 1Cadence Pharmaceuticals Updates Omigard 28TM 29 Clinical Timeline 3058 2Cadence Pharmaceuticals Updates Omigard 28TM 29 Clinical Timeline 3058 3Cadence Pharmaceuticals Updates Omigard 28TM 29 Clinical Timeline 3058 4
...o Company Oncology Programs to be Presented, SOUTH...-FirstCall/ -- Cytokinetics, Incorporated announce...data will be,presented at the 2007 Annual Meeting ...ACR) to be held from April 14- 18, 2007 in,Los Ang...cology,programs at Cytokinetics and will present d...
...--(BUSINESS WIRE)--Apr 9, 2007 -,GlaxoSmithKline (...DLR) today announced data from Study 767905/014 an...rogram for,alvimopan (Entereg/Entrareg(R))., Study...(12,month) study, was designed to evaluate the lon... twice daily in patients taking,opioids for chroni...
Other Medicine Technology:Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 2Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 3Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 5Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 6Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 7GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 2GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 3GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 4GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 5GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 6GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 7
Wilbrandt-binkhorst irrigating cannula.
Binkhorst, length 18 mm.
Wilbrandt-Binkhorst Cannula have a smooth blunt tip end opening.
Army navy retractor set.
Medicine Products: